3D *In Vivo* Imaging from PerkinElmer

Learn about the FMT preclinical in vivo imaging system from PerkinElmer, in this interview at AACR 2011. This fluorescence based system uses non-invasive deep tissue imaging to generate 3D tomographic quantitative images of small animal models. Learn about the portfolio of fluorescence reagents designed to cover a number of disease states. These include activatable agents for in vivo imaging of biological processes, targeted agents which enable specific areas of interest to be detected and measured, and vascular agents for looking at the integrity of entire vascular system.